Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe

TICKERS: CCO; CCJ

Another Uranium Company to Slash Production in 2018
Research Report

Share on Stocktwits

Source:

A BMO Capital Markets report describes the implications of this cutback in production for the uranium market.

In a Dec. 4 research note, BMO analysts Alexander Pearce and Edward Sterck reported that beginning in January 2018, Kazatomprom plans to reduce uranium production by 20% over the next three years to, as the Kazakh state uranium company phrased it, "better align its output with demand." Between 2018 and 2020, it will suspend a total of about 28.6 million pounds (28.6 Mlb) of uranium production, with roughly 10.4 Mlb of it being held back in 2018, according to Kazatomprom's estimates.

For the three-year period, with its uranium production deferral, Kazatomprom's uranium production, per BMO calculations, will be "between 4.5 and 12 Mlb lower than our current estimate (2018 to 2020) or between 3 and 7% of total global mine supply," the analysts indicated.

Considering the impact of Kazatomprom's cutback on total global uranium supply in 2018 alone, BMO noted that supply had already taken a cut with Cameco Corp.'s (CCO:TSX; CCJ:NYSE) announcement to suspend production at McArthur River for 10 months in 2018. BMO estimated the resulting supply decrease due to Cameco to be 20 Mlb "including new reactor buffer inventory build," or 13 Mlb excluding that build, they added.

Kazatomprom's plan to withhold about 4.5 Mlb of uranium supply "represents a deepening of the deficit in 2018 to ~25 Mlb on our forecast including buffer inventory build or ~17 Mlb excluding buffer inventory build," the analysts wrote.

Kazatomprom's uranium production decrease also is "likely to add support to the uranium price, particularly following the recent suspension at McArthur River," the BMO report stated. It "sends further signals to utilities that future uranium supplies are by no means guaranteed at current prices."

Want to read more Energy Report articles like this? Sign up for our free e-newsletter, and you'll learn when new articles have been published. To see a list of recent articles and interviews with industry analysts and commentators, visit our Streetwise Interviews page.

Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Streetwise Reports does not accept stock in exchange for its services. Click here for important disclosures about sponsor fees. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article.





Want to read more about Uranium investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe